HSPA5 and familial pancreatic carcinoma: Vig et al. [31] and Cui et al. [32] found that GRP78 and miR-495-3p could be regarded as the outcome measures of pancreatic cancer and gastric cancer, which showed that the two had great potential in future clinical medical evaluation.